Hostname: page-component-cd9895bd7-gbm5v Total loading time: 0 Render date: 2024-12-25T05:01:26.405Z Has data issue: false hasContentIssue false
  • English
  • Français

Management of Early Prostatic Cancer in the Nordic Countries: Variations in Clinical Policies and Physicians' Attitudes Toward Radical Treatment Options

Published online by Cambridge University Press:  10 March 2009

Pia M. Jonsson ,
Bent Danneskiold-Samsøe ,
Torhild Heggestad ,
Peter Iversen  and
Seppo Leisti
Pia M. Jonsson
Affiliation:
Swedish Institute for Health Services Development (Spri)
Bent Danneskiold-Samsøe
Affiliation:
Danish Hospital Institute
Torhild Heggestad
Affiliation:
Norwegian Institute of Hospital Research
Peter Iversen
Affiliation:
Rigshospitalet, University of Copenhagen
Seppo Leisti
Affiliation:
The Association of Finnish Local Authorities
Get access Rights & Permissions [Opens in a new window]

Abstract

To explore the treatment of patients with early localized prostatic carcinoma, we surveyed the departments of urology and general surgery in Denmark, Finland, Norway, and Sweden. Clinical policies and physicians' attitudes toward the radical treatment options varied widely between the countries. A correlation seems to exist between practice patterns and national attitudes toward special technologies.

Type
General Essays
Information
International Journal of Technology Assessment in Health Care , Volume 11 , Issue 1 , Winter 1995 , pp. 66 - 78
Copyright
Copyright © Cambridge University Press 1995

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1.Adolfsson, J. Radical prostatectomy for localized prostatic cancer: A review of current literature. In Pharmacological treatment of prostatic cancer. Uppsala, Sweden: Medical Products Agency, Workshop Report 1993, 3, 43–54.Google Scholar
2.Andersen, T. F., & Mooney, G. (eds.). The challenges of medical practice variations. Basingstoke, U.K.: Macmillan, 1990.CrossRefGoogle Scholar
3.Bagshaw, M. A., Cox, R. S., & Ramback, J. E.Radiation therapy for localized prostate cancer: Justification by long term follow up. Urologic Clinics of North America, 1990, 17, 787–802.CrossRefGoogle ScholarPubMed
4.Black, W. C., & Welch, H. G.Advances in diagnostic imaging and overestimation of disease prevalence and the benefits of therapy. New England Journal of Medicine, 1993, 328, 1237–43.CrossRefGoogle ScholarPubMed
5.Borghede, G. Radiation therapy of localized prostatic cancer stage T0-T3. In Pharmacological treatment of prostatic cancer. Uppsala, Sweden: Medical Products Agency, Work shop Report 1993, 3, 55–68.Google Scholar
6.Cancer incidence in Denmark 1988. Copenhagen: Danish Cancer Society, Danish Cancer Registry, Institute of Cancer Epidemiology, 1991.Google Scholar
7.Cancer incidence in Sweden 1988. Stockholm: National Board of Health and Welfar The Cancer Registry, Allmänna Förlaget (distr.), 1992.Google Scholar
8.Coulter, A., McPherson, K., & Vessey, M.Do British women undergo too many or too few hysterectomies? Social Science and Medicine, 1988, 27, 987–94.CrossRefGoogle ScholarPubMed
9.Eddy, D.Variation in physician practice: The role of uncertainty. Health Affairs, 1984, 3, 74–89.CrossRefGoogle ScholarPubMed
10.The Finnish Cancer Registry.Google Scholar
11.Goodman, C. S. Profiles of 20 technology assessment programs. In Institute of Medicine, Division of Health Sciences Policy: Assessing medical technologies. Washington, D.C.: National Academy Press, 1985, 255–489.Google Scholar
12.The Icelandic Cancer Registry.Google Scholar
13.Incidence of cancer in Norway 1989. Oslo: Cancer Registry of Norway, 1990.Google Scholar
14.Iversen, P., & Torp-Pedersen, I.Current opinion in urology, 1991, 1.CrossRefGoogle Scholar
15.Johansson, J.-E., Adami, H.-O., Anderson, S.-O., et al. High 10-year survival rate in patients with early untreated prostatic cancer. Journal of the American Medical Association, 1992, 267, 2191–96.CrossRefGoogle ScholarPubMed
16.Lee, F.Transrectal ultrasound: Diagnosis and staging of prostatic carcinoma. Urology, 1989, 33 (suppl 5), 5–10.CrossRefGoogle ScholarPubMed
17.Madsen, P. O., et al. Treatment of localized prostatic cancer: Radical prostatectomy versus placebo — A 15-year follow-up. Scandinavian Journal of Urology and Nephrology, 1988, 110 (suppl). 95–100.Google ScholarPubMed
18.Paulson, D. F., Moul, J. W., & Walther, P. J.Radical prostatectomy for clinical stage T1-2N0M0 prostatic adenocarcinoma: Long-term results. Journal of Urology, 1990, 144, 1180–84.CrossRefGoogle ScholarPubMed
19.Polednak, A. P.Geographic variation in the treatment of prostate cancer in Connecticut. International Journal of Technology Assessment in Health Care, 1993, 9, 304–10.CrossRefGoogle ScholarPubMed
20.Pollack, H. M., & Schnall, M. D. Magnetic resonance imaging in carcinoma of the prostate. Prostate, 1992 (suppl 4), 17–31.CrossRefGoogle Scholar
21.Stamey, T. A.Diagnosis of prostate cancer: A personal view. Journal of Urology, 1992, 147, 830–32.CrossRefGoogle ScholarPubMed
22.Union Internationale Contre le Cancer. TNM classification of malignant tumours. Geneva, 1978.Google Scholar
23.Wennberg, J. E., Barnes, B. A., & Zubkoff, M.Professional uncertainty and the problem of supplier-induced demand. Social Science and Medicine, 1982, 16, 811–24.CrossRefGoogle ScholarPubMed
24. Whitmore, W. F., Warner, J. A., & Thomson, I. M.Expectant management of localized prostatic cancer. Cancer, 1991, 67, 1091–96.3.0.CO;2-J>CrossRefGoogle ScholarPubMed